open access

Vol 43, No 4 (2012)
Untitled
Submitted: 2012-10-25
Published online: 2012-10-01
Get Citation

Analysis of ex vivo Apoptosis of B and T cells from Peripheral Blood and Bone Marrow of Patients with Chronic Lymphocytic Leukemia

Agnieszka Bojarska-Junak1, Iwona Hus2, Karolina Olszewska-Bożek1, Sylwia Chocholska2, Ewa Wąsik-Szczepanek2, Waldemar Tomczak2, Justyna Miłczak3, Anna Dmoszyńska2, Jacek Roliński1
DOI: 10.1016/S0001-5814(12)70005-1
·
Acta Haematol Pol 2012;43(4):336-341.
Affiliations
  1. Katedra i Zakład Immunologii Klinicznej, UM w Lublinie Kierownik: prof. dr hab. n. med. Jacek Roliński
  2. Katedra i Klinika Hematoonkologii i Transplantacji Szpiku, UM w Lublinie Kierownik: prof. dr hab. n. med. Anna Dmoszyńska
  3. Oddział Anestezjologii i Intensywnej Terapii Dziecięcy Szpital Kliniczny im. prof. Antoniego Gębali Kierownik: dr n. med. Witold Lesiuk

open access

Vol 43, No 4 (2012)
Untitled
Submitted: 2012-10-25
Published online: 2012-10-01

Abstract

In this study we analyzed selected parameters of apoptosis in leukemic cells from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia (CLL). The percentage of apoptotic leukemic B cells (Δψmlow/CD19+) was significantly lower in peripheral blood (median: 0.99%) than in bone marrow (median: 1.41%) (p<0.0001). These data can support the idea that these two compartments might have different proliferative statuses. There was an inverse correlation between the ex vivo percentage of apoptotic cells and lymphocytosis (R=-0.34; p<0.01), and a direct correlation between the percentage of PB apoptotic B cells and the Rai stage (R=0.42; p<0.05). The percentage of Δψmlow/CD19+ cells was significantly higher in ZAP-70-positive patients than from ZAP-70-negative patients (p<0.01). There was also a significant difference in the median percentage of apoptotic leukemic B cells between the patients carrying del(11q22.3) or/and del(17p13.1) (2.7%) and the patients without these unfavorable genetic aberrations (1.6%) (p<0.01). The B cells from ZAP-70-positive patients with more aggressive disease seem to be more susceptible to spontaneous apoptosis than those from ZAP-70-negative patients. We conclude that the evaluation of ex vivo apoptosis might provide new important information concerning the biology and prognosis of CLL.

Abstract

In this study we analyzed selected parameters of apoptosis in leukemic cells from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia (CLL). The percentage of apoptotic leukemic B cells (Δψmlow/CD19+) was significantly lower in peripheral blood (median: 0.99%) than in bone marrow (median: 1.41%) (p<0.0001). These data can support the idea that these two compartments might have different proliferative statuses. There was an inverse correlation between the ex vivo percentage of apoptotic cells and lymphocytosis (R=-0.34; p<0.01), and a direct correlation between the percentage of PB apoptotic B cells and the Rai stage (R=0.42; p<0.05). The percentage of Δψmlow/CD19+ cells was significantly higher in ZAP-70-positive patients than from ZAP-70-negative patients (p<0.01). There was also a significant difference in the median percentage of apoptotic leukemic B cells between the patients carrying del(11q22.3) or/and del(17p13.1) (2.7%) and the patients without these unfavorable genetic aberrations (1.6%) (p<0.01). The B cells from ZAP-70-positive patients with more aggressive disease seem to be more susceptible to spontaneous apoptosis than those from ZAP-70-negative patients. We conclude that the evaluation of ex vivo apoptosis might provide new important information concerning the biology and prognosis of CLL.

Get Citation

Keywords

CLL; ex vivo apoptosis; CMXRos

About this article
Title

Analysis of ex vivo Apoptosis of B and T cells from Peripheral Blood and Bone Marrow of Patients with Chronic Lymphocytic Leukemia

Journal

Acta Haematologica Polonica

Issue

Vol 43, No 4 (2012)

Pages

336-341

Published online

2012-10-01

Page views

149

Article views/downloads

145

DOI

10.1016/S0001-5814(12)70005-1

Bibliographic record

Acta Haematol Pol 2012;43(4):336-341.

Keywords

CLL
ex vivo apoptosis
CMXRos

Authors

Agnieszka Bojarska-Junak
Iwona Hus
Karolina Olszewska-Bożek
Sylwia Chocholska
Ewa Wąsik-Szczepanek
Waldemar Tomczak
Justyna Miłczak
Anna Dmoszyńska
Jacek Roliński

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl